A product containing 1.8 mg dihydrocodeine per 100 mL, or 90 mg per dosage unit, with one or more active non-narcotic ingredients in recognized therapeutic amounts, is scheduled as:

Prepare for the Montana MPJE. Study with flashcards and multiple choice questions, each question has hints and explanations. Get ready for your exam!

Multiple Choice

A product containing 1.8 mg dihydrocodeine per 100 mL, or 90 mg per dosage unit, with one or more active non-narcotic ingredients in recognized therapeutic amounts, is scheduled as:

Explanation:
Understanding how combination opioid products are scheduled helps. Dihydrocodeine products are classified by how much of the narcotic is in each dosage unit and whether non-narcotic active ingredients are present in recognized therapeutic amounts. When a product contains dihydrocodeine in limited amounts and includes non-narcotic ingredients in therapeutic amounts, it falls into Schedule III. The given product has 90 mg of dihydrocodeine per dosage unit (the maximum for a Schedule III combination) and includes one or more non-narcotic active ingredients in recognized therapeutic amounts, with a concentration of 1.8 mg per 100 mL. These factors align with Schedule III. If the amount per dosage unit exceeded 90 mg or there were no non-narcotic ingredients, it would be Schedule II. If there were no narcotic ingredients at all, it could be Not scheduled. Therefore, this product is Schedule III.

Understanding how combination opioid products are scheduled helps. Dihydrocodeine products are classified by how much of the narcotic is in each dosage unit and whether non-narcotic active ingredients are present in recognized therapeutic amounts. When a product contains dihydrocodeine in limited amounts and includes non-narcotic ingredients in therapeutic amounts, it falls into Schedule III. The given product has 90 mg of dihydrocodeine per dosage unit (the maximum for a Schedule III combination) and includes one or more non-narcotic active ingredients in recognized therapeutic amounts, with a concentration of 1.8 mg per 100 mL. These factors align with Schedule III. If the amount per dosage unit exceeded 90 mg or there were no non-narcotic ingredients, it would be Schedule II. If there were no narcotic ingredients at all, it could be Not scheduled. Therefore, this product is Schedule III.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy